Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Examining multiple sclerosis through the eyes of a child.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
Fingolimod-associated amenorrhea: a report of three cases.
Vitamin D in inflammatory diseases.
Significant increase in the prevalence of multiple sclerosis in iran in 2011.
Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study.
Endothelial microparticles interact with and support the proliferation of T cells.
Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.
Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier.
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy.
Development of a Standardized MRI Scoring Tool for CNS Demyelination In Children.
Multiple sclerosis eye-brain dynamic correlation.
ALCAM - Novel multiple sclerosis locus interfering with HLA-DRB1*1501.
MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod).
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
How can we exploit the brain's ability to repair itself?
Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.
Single nucleotide polymorphisms with cis-regulatory effects on long non-coding transcripts in human primary monocytes.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.

Pages